A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis.
Artigo
em Inglês
| IMSEAR
| ID: sea-65783
ABSTRACT
BACKGROUND:
Kamalahar is an indigenous preparation reported to be beneficial in acute viral hepatitis.AIMS:
To evaluate the efficacy of Kamalahain acute viral hepatitis in a double-blind, placebo-controlled study.METHODS:
Fifty two patients with acute viral hepatitis were randomized to receive either Kamalahar 500 mg or a matched placebo three times a day for 15 days. Forty four patients (Kamalahar 20; placebo 24) completed the trial.RESULTS:
Improvement in clinical signs was more marked with Kamalahar compared to placebo. The fall in serum bilirubin (p < 0.001), SGPT (p < 0.001) and serum alkaline phosphatase (p < 0.005) at day 15 was significantly greater with the drug. No significant side effects were observed.CONCLUSION:
Kamalahar offers therapeutic promise in acute viral hepatitis.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Feminino
/
Humanos
/
Masculino
/
Extratos Vegetais
/
Método Duplo-Cego
/
Doença Aguda
/
Adolescente
/
Adulto
/
Hepatite Viral Humana
/
Ayurveda
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Inglês
Ano de publicação:
1993
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS